CLINICAL_TRIALS
research
· 2022-02-14
Clinical Trial Update: Impairment of Gastric Emptying During Acute Phase of Myocardial Infarction. Impact on Oral Antiplatelet Treatment Efficacy. The GASTRIM Study. [Phase 4]
Summary
A Phase 4 trial investigating how impaired gastric emptying during the acute phase of myocardial infarction affects the efficacy of oral antiplatelet treatment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hospital, Bordeaux | Conditions: Impairment of Gastric Emptying, Acute Phase of Myocardial Infarction | Phase 4 | Status: COMPLETED